No Data
Tibet Cheezheng Tibetan Medicine: Summary of Half-Year Report in 2024.
Tibet Cheezheng Tibetan Medicine: Half-year report for the year 2024.
Tibet Cheezheng Tibetan Medicine: 2024 Half-Year Performance Bulletin
Tibet Cheezheng Tibetan Medicine (002287.SZ) had a net income of 0.326 billion yuan in the first half of the year, a year-on-year increase of 4.42%.
Qizheng Tibetan Medicine (002287.SZ) released its 2024 half-yearly report. Within the reporting period, the company achieved a total operating revenue of 1.01 billion yuan, representing a 21.70% increase over the same period last year. The company achieved an operating profit of 0.367 billion yuan, which was a 7.85% increase over the same period last year; the net income attributable to shareholders of the listed company was 0.326 billion yuan, representing a 4.42% increase year-on-year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.228 billion yuan, representing a 4.30% increase over the same period last year; and the basic earnings per share was 0.6150 yuan.
As of June 28, 2024, the total number of shareholders of Tibet Cheezheng Tibetan Medicine (002287.SZ) is 20,044.
On July 2nd, Gelonhui reported that as of June 28th, 2024, the total number of shareholders in Tibet Cheezheng Tibetan Medicine (002287.SZ) was 20,044.
Tibet Cheezheng Tibetan Medicine (002287.SZ) annual equity distribution for 2023: 4.80 yuan per 10 shares, registration of shares on July 3.
Tibet Cheezheng Tibetan Medicine (002287.SZ) announced that the company's annual equity distribution plan for 2023 is: based on the company's existing total share capital excluding repurchased shares, RMB 4.80 per 10 shares will be distributed to all shareholders in cash (including tax). The equity distribution record date for this time is July 3, 2024, and the ex-dividend date is July 4, 2024.
No Data
